Ashley Gallagher

The Act is set to end at the end of 2024, which will affect pharmacists’ abilities to administer COVID-19 tests, vaccines, and treatment that are distributed by the federal government.

The approval is based on clinical studies that demonstrate the management of heart rate with minimal reductions to blood pressure.

The disappearance could impact updates for surveillance strategies and vaccine development.

The label includes postmarking reports showing rare instances of pulmonary aspiration for patients undergoing procedures that require general anesthesia or deep sedation.

In the analysis, 34.7% of commercially insured patients with chronic obstructive pulmonary disease or asthma received an influenza vaccination.

Despite their proven abilities, organizations such as the American Medical Association still oppose so-called “scope creep.”

The designation follows 2 previous orphan drug designations for pancreatic cancer and soft tissue sarcoma.

Kristi Veis discusses the importance of flu vaccinations and the role of pharmacists in administering them.

Erin Rexroth, associate director of marketing for NCPA, discussed how pharmacies can utilize marketing strategies to drive awareness and patient engagement.

The study investigated faricimab-svoa (Vabysmo) as treatment of diabetic macular edema for patients in racial and ethnic groups that are often underrepresented in trials.